Effects of scFOS on Stool Frequency in People With Functionnal Constipation
NCT ID: NCT01847950
Last Updated: 2018-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2012-11-30
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of scFOS on Increase in Stool Frequency in Constipated People
NCT03707002
Trial on Short-chain Fructooligosaccharides, Microbiota, and Constipation in Adults
NCT02140749
Evaluation of the Effect of Chicory Inulin-type Fructans in Constipated Adults
NCT05447481
Effect of Probiotics on Functional Constipation in Adults
NCT04437147
Dietary Supplementation Effects on Bowel Movement Frequency and Intestinal Biological Markers in Seniors Presenting Slowed Intestinal Transit
NCT04304170
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
short-chain fructo-oligosaccharides
Short-chain fructo-oligosaccharides are consummed at 5g/day for 6 weeks
Short-chain fructo-oligosaccharides
Short-chain fructo-oligosaccharides are consummed at 5g/day for 6 weeks
Maltodextrin
maltodextrins are consummed at 5g/day for 6 weeks
Maltodextrin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Short-chain fructo-oligosaccharides
Short-chain fructo-oligosaccharides are consummed at 5g/day for 6 weeks
Maltodextrin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* subjects consuming more than 25g/day of dietary fibres
* pregnant women
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Syral
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Benamouzig, Pr
Role: PRINCIPAL_INVESTIGATOR
CRNH - CRV Avicenne Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CRNH-CRV Avicenne Hospital
Bobigny, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ConstiFOS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.